Evidence map›Paper›PMID 33382743›Full record

ArticlePloS one2020

Longitudinal trends in PrEP familiarity, attitudes, use and discontinuation among a national probability sample of gay and bisexual men, 2016-2018.

Ian W Holloway, Evan A Krueger, Ilan H Meyer, Marguerita Lightfoot, David M Frost, Phillip L Hammack

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
0.5field-weighted citation impact, top 22% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 27 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Review
  10. Article
  11. Article
  12. Article
  13. Barriers and Facilitators to Participation in Long-Acting Injectable PrEP Research Trials for MSM, Transgender Women, and Gender-Nonconforming People of Color.AIDS education and prevention : official publication of the International Society for AIDS Education · 2021
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 6 institutions in 2 countries.

Ian W HollowayDepartment of Social Welfare, UCLA Luskin School of Public Affairs, Los Angeles, California, United States of America.ORCID 0000-0001-7454-8632
Evan A KruegerDepartment of Preventive Medicine, USC Keck School of Medicine, Los Angeles, California, United States of America.
Ilan H MeyerWilliams Institute, UCLA School of Law, Los Angeles, California, United States of America.ORCID 0000-0003-2667-4583
Marguerita LightfootDepartment of Medicine, University of California, San Francisco, California, United States of America.
David M FrostDepartment of Social Science, University College, London, United Kingdom.
Phillip L HammackDepartment of Psychology, University of California, Santa Cruz, California, United States of America.
Keck Hospital of USC · USLos Angeles LGBT Center · USUniversity College London · GBUniversity of California, San Francisco · USUniversity of California, Santa Cruz · USWilliams (United States) · US

Funding

UCLA Rapid, Relevant, Rigorous Implementation Science HubP30MH058107 · NIMH · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Nina Thawata Harawa · 1997 to 2026
$53.5M
Scientific and Technical CoreP2CHD041022 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI Martha Jane Bailey · 2016 to 2026
$6.9M
Identity Stress and Health in Three Cohorts of LGB individualsR01HD078526 · NICHD · UNIVERSITY OF CALIFORNIA LOS ANGELES · PI MEYER, ILAN H · 2014 to 2018
$4.1M
NICHD NIH HHS P2C HD041022NICHD NIH HHS R01 HD078526NIMH NIH HHS P30 MH058107
6 · The paper itself

Abstract

This study explored familiarity with, attitudes toward, uptake and discontinuation of PrEP (Pre-exposure prophylaxis) among a national probability sample of gay and bisexual men. PrEP is one of the most effective biomedical HIV prevention strategies; however, use among gay and bisexual men remains low within the United States. This study used a national probability sample of gay and bisexual men from three age cohorts of men (18-25, 34-41, and 52-59 years at wave 1) who completed three annual surveys between March 2016 and March 2018 (N at wave 1 = 624). Recruitment occurred through a Gallup dual-frame sampling procedure; results for this study came from eligible individuals who consented to be part of the self-administered online or mailed survey questionnaire. We used descriptive data with sampling weights to understand trends in PrEP familiarity, PrEP attitudes and PrEP use across all three time points. Next, PrEP uptake and discontinuation were assessed among men completing all three surveys and who remained eligible for PrEP at all three time points (N = 181). PrEP familiarity increased considerably between 2016 and 2018 among those eligible for PrEP (from 59.8% from wave 1 to 92.0% at wave 3). Favorable attitudes toward PrEP increased more modestly (from 68.3% at wave 1 to 72.7% at wave 3). While PrEP use increased by 90% between the two time points (from 4.1% in 2016 to 7.8% in 2018), this represented a small percentage of overall uptake among eligible participants across time (6.6%). Among respondents who reported PrEP use at wave 1 or wave 2, 33.3% subsequently discontinued PrEP use at a later wave. Findings indicate modest increases in PrEP use between 2016 and 2018 in a national probability sample of sexually-active gay and bisexual men. PrEP discontinuation was high and suggests the need for further research into gay and bisexual men's PrEP discontinuation and persistence.

Indexed as

Drug MonitoringHealth Knowledge, Attitudes, PracticeAdolescentAdultHIV InfectionsHumansLongitudinal StudiesMaleMedication AdherenceMiddle AgedPre-Exposure ProphylaxisSampling StudiesSexual and Gender MinoritiesUnited StatesYoung Adult

Identifiers

PMID33382743
PMCPMC7775083
OpenAlexW3115208038

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.